Walleye Capital
EBS icon

Walleye Capital’s Emergent Biosolutions EBS Stock Holding History

Walleye Capital’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4
Closed -$49 – 4539
2025
Q4 		$49 Sell
4
-123
-97% -$1.32K ﹤0.01% 4449
2025
Q3 		$1.12K Sell
127
-11,279
-99% -$87.7K ﹤0.01% 4371
2025
Q2 		$72.8K Buy
+11,406
New +$65.3K ﹤0.01% 3912
2025
Q1 		– Sell
-5,993
Closed -$49.6K – 4445
2024
Q4 		$57.3K Sell
5,993
-18,265
-75% -$168K ﹤0.01% 4327
2024
Q3 		$203K Sell
24,258
-72,349
-75% -$658K ﹤0.01% 3999
2024
Q2 		$659K Buy
96,607
+65,607
+212% +$282K ﹤0.01% 3257
2024
Q1 		$78.4K Sell
31,000
-238,690
-89% -$538K ﹤0.01% 4512
2023
Q4 		$647K Buy
269,690
+227,596
+541% +$535K ﹤0.01% 2734
2023
Q3 		$143K Sell
42,094
-142,404
-77% -$789K ﹤0.01% 3761
2023
Q2 		$1.36M Buy
184,498
+75,921
+70% +$704K ﹤0.01% 1598
2023
Q1 		$1.12M Buy
108,577
+25,575
+31% +$309K 0.02% 1077
2022
Q4 		$980K Buy
83,002
+77,571
+1,428% +$1.2M 0.02% 1015
2022
Q3 		$114K Sell
5,431
-8,342
-61% -$232K ﹤0.01% 2371
2022
Q2 		$428K Buy
+13,773
New +$470K 0.01% 1126
2021
Q3 		– Sell
-7,050
Closed -$444K – 1645
2021
Q2 		$444K Buy
+7,050
New +$453K 0.02% 805
2018
Q3 		$227K Buy
+3,445
New +$201K 0.11% 208

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Walleye Capital's EBS Position: Q1 2026 in Review

Walleye Capital sold out of Emergent Biosolutions (EBS) in Q1 2026, closing a stake of 4 shares — an estimated $49 sold.

Walleye Capital first reported a position in EBS in Q3 2018 and held it in 16 quarters. The position peaked at $1.36M in Q2 2023. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Walleye Capital reported no remaining Emergent Biosolutions position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 4 Emergent Biosolutions shares in Q1 2026, an estimated $49.
  • Walleye Capital first reported a position in Emergent Biosolutions in Q3 2018 and held it in 16 quarters.
  • Walleye Capital's Emergent Biosolutions position peaked at $1.36M in Q2 2023.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.